Overview

Photodynamic Therapy (PDT) With Methyl Aminolevulinate (MAL) Cream in Patients With Skin Type V or IV With Acne Vulgaris

Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
In this multicenter study, patients with dark skin and acne vulgaris will be included. The patients will receive treatment with MAL PDT and placebo PDT.
Phase:
Phase 2
Details
Lead Sponsor:
Photocure
Treatments:
Aminolevulinic Acid
Methyl 5-aminolevulinate